This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.
Company Filing History:
2 out of 823 
2 out of 2 Years Active: 2026
Title: Ingrid Devillers: Innovator in Pharmaceutical Sciences
Introduction
Ingrid Devillers is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of macrocyclic compounds. With a total of 2 patents to her name, her work has the potential to impact various therapeutic areas.
Latest Patents
Ingrid's latest patents include innovative macrocyclic compounds, compositions, and methods of using them. The present disclosure encompasses CFTR modulators, pharmaceutical compositions, and methods of making and utilizing these compounds. Her research focuses on enhancing the efficacy of treatments through novel chemical structures.
Career Highlights
Throughout her career, Ingrid has worked with notable companies such as Genzyme Corporation and Sionna Therapeutics Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation.
Collaborations
Ingrid has collaborated with various professionals in her field, including her coworker George Topalov. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Ingrid Devillers stands out as an influential inventor in the pharmaceutical industry. Her contributions through her patents and collaborations continue to pave the way for advancements in medical treatments.